계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
RA Capital Management
company
Investments
Number of Investments
Number of Lead Investments
41
15
RA Capital Management has made 41 investments. Their most recent investment was on
Dec 7, 2022, when Apogee Therapeutics, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Dec 7, 2022 | Apogee Therapeutics | Series B | — | Biotechnology | — |
| Dec 7, 2022 | Vor Biopharma | Post-IPO Equity | — | Biotechnology | Yes |
| Nov 15, 2022 | Jnana Therapeutics | Series C | — | Biotechnology | — |
| Nov 14, 2022 | MBX Biosciences | Series B | — | Biotechnology | — |
| Sep 12, 2022 | Nimbus Therapeutics | Series Unknown | — | Biotechnology | — |
| Aug 2, 2022 | Empatica | Series B | — | Artificial Intelligence | Yes |
| Mar 31, 2022 | Incyclix Bio | Series B | — | Biotechnology | — |
| Feb 22, 2022 | Somatus | Series E | — | Health Care | — |
| Feb 16, 2022 | Star Therapeutics | Series Unknown | — | — | |
| Jan 25, 2022 | Metagenomi | Series B | — | Artificial Intelligence | — |
| Dec 7, 2021 | Freenome | Series D | — | Biotechnology | Yes |
| Aug 18, 2021 | Jnana Therapeutics | Series B | — | Biotechnology | Yes |
| Jul 13, 2021 | Nimbus Therapeutics | Series Unknown | — | Biotechnology | — |
| Jun 29, 2021 | Element Biosciences | Series C | — | Biotechnology | — |
| Apr 29, 2021 | Forge Biologics | Series B | — | Biotechnology | Yes |
| Apr 15, 2021 | Alchemab Therapeutics | Series A | — | Biotechnology | Yes |
| Mar 31, 2021 | Scribe Therapeutics | Series B | — | Biotechnology | — |
| Mar 1, 2021 | Tenaya Therapeutics | Series C | — | Biopharma | — |
| Jan 19, 2021 | Verve Therapeutics | Series B | — | Biotechnology | — |
| Nov 12, 2020 | Metagenomi | Series A | — | Artificial Intelligence | Yes |
| Oct 14, 2020 | Nimbus Therapeutics | Series Unknown | — | Biotechnology | — |
| Aug 26, 2020 | Freenome | Series C | — | Biotechnology | — |
| Jul 7, 2020 | Vor Biopharma | Series B | — | Biotechnology | Yes |
| Jun 26, 2020 | Element Biosciences | Series B | — | Biotechnology | — |
| Jun 15, 2020 | Novavax | Post-IPO Equity | — | Biotechnology | Yes |
| Dec 5, 2019 | Black Diamond Therapeutics | Series C | — | Biotechnology | — |
| Jul 24, 2019 | Freenome | Series B | — | Biotechnology | Yes |
| Feb 14, 2019 | Vor Biopharma | Series A | — | Biotechnology | Yes |
| Jan 9, 2019 | Black Diamond Therapeutics | Series B | — | Biotechnology | Yes |
| Nov 27, 2017 | Medeor Therapeutics | Series B | — | Biotechnology | Yes |
| Jan 6, 2017 | AgriMetis | Series B | — | Agriculture | Yes |
| Jul 18, 2016 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| Apr 13, 2016 | Kala Pharmaceuticals | Series C | — | Biotechnology | — |
| Jul 22, 2015 | KalVista Pharmaceuticals | Series B | — | Biotechnology | Yes |
| Jun 22, 2015 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| Apr 6, 2015 | Natera | Series F | — | Biotechnology | — |
| Jan 5, 2015 | Moderna Therapeutics | Series E | — | Biotechnology | — |
| Nov 12, 2014 | Blueprint Medicines | Series C | — | Bioinformatics | — |
| Nov 6, 2013 | Ocera Therapeutics | Post-IPO Equity | — | Biopharma | — |
| Jul 25, 2012 | Bluebird Bio | Series D | — | Biotechnology | — |
| Jan 1, 2007 | Eiger BioPharmaceuticals | Seed | — | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
